Prime Highlights
- Stanford-led research shows the shingles vaccine may reduce dementia risk by 20%, offering a promising preventive strategy.
- The vaccine also appears to slow dementia progression in those already diagnosed, suggesting potential therapeutic benefits.
Key Facts
- The study analyzed over 280,000 adults aged 71–88 in Wales using a near-random vaccination policy for reliable results.
- Vaccinated individuals not only had lower dementia rates but also fewer cases of shingles, highlighting the vaccine’s dual benefits.
Background
A new study led by Stanford Medicine has found that the shingles vaccine may lower the risk of dementia by 20%, offering the strongest evidence so far that vaccination could play a role in preventing the condition. The findings, based on health records from older adults in Wales, were published in Nature and point to a potential preventive strategy already available in public health systems.
Researchers examined more than 280,000 adults aged 71 to 88 and used a unique vaccination policy in Wales to compare individuals who narrowly qualified for the shingles vaccine with those who did not. The program, launched in 2013, allowed only people who were 79 years old on a specific date to receive the vaccine. This small age cutoff created a near-random division between vaccinated and unvaccinated groups, giving the study unusual strength and reliability.
Over the following seven years, individuals who received the vaccine were significantly less likely to develop dementia and also had fewer cases of shingles, which the vaccine is designed to prevent. Dementia rates among the vaccinated group were 20% lower, a result that held steady across different forms of analysis.
A companion study in Cell found that the vaccine may also help people already diagnosed with dementia by slowing its progression. Researchers observed fewer deaths caused by dementia among vaccinated individuals, suggesting a possible therapeutic benefit.
The protective effect was notably stronger in women, a trend possibly linked to differences in immune response.
Scientists say these findings show that viruses affecting the nervous system can increase the risk of dementia. More research, including randomized trials, is still needed, but the results give hope for a simple and safe way to lower dementia’s worldwide impact.
